Healthy Aging & Longevity Ingredients Market

How Big Is Healthy Aging & Longevity Ingredients Market in 2026?

USD 26.5 billion in 2026 and USD 68.1 billion by 2036 at a 9.9% CAGR.

Demand for healthy aging & longevity ingredients is projected to expand at 9.9% CAGR between 2026 and 2036, increasing valuation from USD 26.5 billion in 2026 to USD 68.1 billion by 2036. UN DESA reported in February 2026 that 1.22 billion people were aged 60 or older in 2025 and projects 2.11 billion by 2050. That age expansion gives ingredient companies a larger base for nutraceutical ingredients designed around mobility and repeat-use nutrition.

Commercial routes differ because demographic need reaches national channels with different claim systems and product rules. USA dietary supplements already reach a large older consumer base through established retail and direct channels. The USA Census Bureau reported in June 2025 that adults aged 65 or older increased 3.1% to 61.2 million during 2024. Japan and European markets require more formal evidence work before comparable benefit language reaches shelves.

Key Takeaways

• Population aging is enlarging the consumer base for nutrition products positioned around preserving mobility and other everyday functions later in life.
• Based on ingredient, proteins are projected to account for 29.0% in 2026 due to their central role in muscle-oriented formulations.
• By application, functional F&B is estimated to hold 41.4% in 2026 owing to regular eating occasions that support repeat consumption.
• The benefit category is forecast to be led by mobility at 48.7% share in 2026 due to its direct connection with everyday independence.
• Commercialization slows if effective doses create sensory or stability problems and proposed benefits lack defensible claim support.
• dsm-firmenich, Glanbia, Kerry, BASF, Gnosis by Lesaffre, IFF, ADM and Lallemand Health Solutions are the eight companies profiled across this market.

Analyst Perspective

"Healthy-aging ingredient selection starts with a defensible benefit claim that formulation teams must fit into a familiar food or supplement format at an effective dose. Commercial value is earned once that evidence survives taste and stability work and the active becomes a product consumers can take repeatedly."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How Is the Healthy Aging & Longevity Ingredients Market Segmented?

The healthy aging & longevity ingredients market is segmented by ingredient, application and benefit with region used for geographic analysis.

Ingredient categories include proteins and collagen plus omega-3 and probiotics alongside botanicals and vitamins across the defined product universe. Application categories comprise functional F&B and supplements plus beverages while benefit categories cover mobility and cognition alongside immunity. Region supplies the geographic view used for country and broader regional analysis across the fixed market taxonomy.

Why Does Functional F&B Lead the Application Category?

Functional F&B puts age-focused nutrition into ordinary eating occasions, but processing heat and shelf life narrow the actives that survive commercial production without reformulation in functional foods.

• In 2026, functional F&B is expected to lead application with 41.4% share because familiar foods can deliver benefits within routines consumers already repeat.
• ADM announced in February 2025 that CP2305 could withstand high-heat and high-water formulation conditions and would reach food manufacturers across North America, Europe and Asia. That resilience lets probiotic ingredients enter functional foods without forcing manufacturers to abandon the intended production route across commercially established lines.

What Makes Proteins Central to the Ingredient Category?

Protein selection begins with serving size because meaningful daily doses can alter texture before lower-dose actives enter an age-focused formulation. dsm-firmenich reported in February 2026 that it introduced compact neutral-taste Mix-in protein granules during 2025 to raise protein intake within familiar foods.

• By ingredient, proteins are estimated to hold 29.0% in 2026 owing to substantial daily dosing and direct use in muscle-oriented nutrition products.
• Formulators compare dairy and plant-based protein sources against taste targets and serving volume as each route must deliver nutrition without overwhelming regular meals or drinks.

What Supports Mobility in the Benefit Category?

Consumers can connect muscle strength and movement with everyday independence, giving product developers a concrete healthy-aging target. Lallemand Health Solutions launched Cerenity in March 2025 following a study in adults aged 60 to 85 that reported mobility and strength improvements.

• Mobility is projected to hold 48.7% share in 2026 owing to formulation routes that combine protein with targeted joint or muscle actives.
• Collagen peptides give formulators a joint-focused route that differs from protein's muscle-oriented role in age-focused products. Omega-3 products require a separate evidence path that matches the mobility benefit claimed for each formulation.

What Are the Drivers, Restraints and Opportunities in the Healthy Aging & Longevity Ingredients Market?

Population aging expands function-focused nutrition demand as claims and formulation requirements slow qualification while application-ready ingredient systems widen commercial use.

• Driver: Defined healthy-aging propositions increase demand for ingredients that can support specific functional benefits in repeat-use nutrition products.
• Restraint: Claims review and effective-dose requirements can delay launch if benefit wording or formulation performance fails internal approval.
• Opportunity: Stable actives can extend healthy-aging nutrition into more food and beverage formats without requiring a separate supplement routine.

Defined Healthy-Aging Propositions Increase Commercial Demand

Healthy-aging demand becomes commercially stronger as brands turn broad longevity interest into defined benefits that can survive formulation and claim review. dsm-firmenich launched its Healthy Longevity platform in April 2025 with nutritional solutions and formulation services for supplement brands developing health-expectancy products. The model gives vitamin supplements and mixed-active concepts a clearer route from evidence selection to repeat-use products without relying on vague age claims.

Claims and Dose Requirements Slow Qualification

A promising active can stall during label review if the proposed benefit exceeds permissible wording or the effective dose disrupts the intended format during final commercial qualification and brand approval. FDA reiterated DSHEA disclaimer requirements in December 2025, so botanical ingredients and other supplement actives need label rules settled early to avoid late packaging changes and repeated formulation work cycles.

Stable Actives Extend Functional-Food Formats

Application-ready functional food ingredients reach more eating occasions when stability survives processing and the effective dose remains acceptable in taste and shelf life. Food and beverage teams can then carry a documented benefit into ordinary routines without asking consumers to add another supplement occasion. Kerry reported in June 2025 that BC30 is highly stable and suitable for varied enhanced foods and beverages, giving formulators a tested route into more processed formats.

Which Country CAGRs Are Profiled in the Healthy Aging & Longevity Ingredients Market?

Country	CAGR
USA	9.4%
UK	8.6%
Germany	7.8%
Japan	7.4%

How Do Country-Level CAGRs Compare in the Healthy Aging & Longevity Ingredients Market?

Profiled rates span 2.0 percentage points and divide into two groups without implying a simple growth ranking. USA and UK combine mature supplement channels with frequent format renewal across retail nutrition categories. Germany and Japan require more structured evidence review to place new benefit claims on established nutrition shelves.

• USA combines heavy supplement use with frequent product testing across retail and direct-to-consumer channels nationwide.
• UK commercial routes use an authorized claims register that makes documentation essential during formulation decisions.
• Germany combines mature nutrition channels with restrained health positioning and tight formulation economics during approval.
• Japan places scientific responsibility on businesses using the foods with function claims route during notification.

Similar CAGRs therefore require different entry plans because claim review and channel economics vary materially. The full report provides country-level CAGR analysis across North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East and Africa.

Country-wise Analysis

• USA brands develop healthy-aging supplements across large retail and direct-to-consumer channels that reward clear functional benefits and let formulators test powders or tablets across several familiar consumer price points nationwide. CDC reported in May 2026 that 75.9% of adults aged 60 or older used a dietary supplement during the prior 30 days, giving age-focused concepts an established route into regular use. Healthy aging & longevity ingredient demand in the USA is forecast to rise at 9.4% CAGR over the forecast period supported by that routine supplement use, while strict claim review makes evidence quality and dose guidance central to brand launch spending.
• UK product teams work inside a claims-controlled supplement and functional-food market that rewards concise benefits but requires permitted wording during taste development and commercial packaging across established retail channels. Healthy aging & longevity ingredient sales in the UK are forecast to expand at 8.6% CAGR by 2036 aided by established retail access and regular product renewal across familiar price tiers and formats. The Department of Health and Social Care updated the Great Britain nutrition and health claims register in May 2026 and permits only authorised claims, making documentation review necessary early in formulation so teams can finalize dose or sensory decisions for retail launch.
• German brand teams face mature pharmacy and nutrition channels with tight price points that cap formulation complexity and place dependable quality ahead of novelty across nationally distributed healthy-aging products. Destatis reported in December 2025 that one person in five was aged 67 or older in 2024 and projects one in four by 2035, expanding the age-focused consumer base for established nutrition formats nationwide. The Germany healthy aging & longevity ingredients sector is projected to record 7.8% CAGR during the assessment period shaped by demographic need, but brand approval favors ingredients with defensible evidence and stable formulation economics across national retail distribution.
• Japanese functional-food developers work under a formal notification route, and the Consumer Affairs Agency revised its foods with function claims guidance in October 2025 while businesses remain responsible for scientific substantiation and compliant benefit wording. Adoption of healthy aging & longevity ingredients in Japan is estimated to expand at 7.4% CAGR through 2036 supported by established functional-food use and targeted benefit communication across mature health-food channels. The route gives documented actives a clearer commercial path than broad longevity language, but local evidence review and precise claim wording remain necessary during conversion of clinical support into shelf-ready products for established retail nutrition programs.

Who Are the Notable Companies in the Healthy Aging & Longevity Ingredients Market?

dsm-firmenich, Glanbia, Kerry, BASF, Gnosis by Lesaffre, IFF, ADM and Lallemand Health Solutions are the notable companies profiled in this market.

Competition is fragmented across broad nutrient platforms and specialists focused on proteins, biotics or micronutrients for defined healthy-aging benefits. Clinical substantiation and formulation support raise entry barriers as brands compare benefit evidence against dose fit during commercial development.

• dsm-firmenich and Glanbia combine multi-class nutrition portfolios with formulation support across food and supplement development for commercial customers.
• Kerry and IFF pair health-science ingredients with application work that addresses processing limits and finished-format requirements across targeted nutrition programs.
• BASF and ADM focus on vitamins or proteins, while Gnosis by Lesaffre and Lallemand Health Solutions concentrate on specialty actives or biotics.

Competitive Benchmarking: Healthy Aging & Longevity Ingredients Market

Company	Ingredient-Class Breadth	Application Support	Benefit Evidence	Geographic Reach
dsm-firmenich	High	High	High	Global
Glanbia	Medium	High	Low	Global
Kerry	Medium	Medium	Medium	Global
BASF	Low	High	Low	Europe and Asia-Pacific
Gnosis by Lesaffre	Low	Medium	High	Global
IFF	Low	Medium	High	Global
ADM	Low	Medium	Low	North America, Europe and Asia
Lallemand Health Solutions	Low	Medium	High	Global

Scoring basis: High ingredient breadth requires three documented classes while Medium requires two and Low identifies one. High application support covers food or beverage and supplement routes while Medium covers one and Low identifies supply without application support. High benefit evidence requires title-specific human evidence or regulated claims while Medium reflects adjacent evidence and Low identifies activity without benefit-specific evidence. Ratings use official company evidence and never infer capability from corporate scale or reputation alone.

Key Developments in the Healthy Aging & Longevity Ingredients Market

• In February 2026, Gnosis by Lesaffre introduced MenaQ7 Olive Oil for oil-based vitamin K2 supplements. The carrier expands formulation options for oil-based healthy-aging supplements built around bone or cardiovascular positioning.
• In December 2025, Lallemand Health Solutions announced Canadian health claims for Cerenity covering muscle health in aging adults and stress. Approved language gives Canadian formulators a clearer route for mobility-focused probiotic products aimed at aging adults.
• In September 2025, BASF completed the sale of its Food and Health Performance Ingredients business to Louis Dreyfus Company. The transferred health portfolio included omega-3 oils and plant sterol esters, leaving BASF focused on vitamins and carotenoids.

Key Players in the Healthy Aging & Longevity Ingredients Market

Multi-Class Nutrition and Application Platforms

• dsm-firmenich
• Glanbia
• Kerry

Vitamin, Protein and Specialty Ingredient Platforms

• BASF
• ADM
• Gnosis by Lesaffre

Biotic Health-Science Specialists

• IFF
• Lallemand Health Solutions

Healthy Aging & Longevity Ingredients Market - Report Scope

Coverage field	Report scope
Market breakdown	By ingredient, application, benefit and region.
Quantitative Units	USD billion.
Market Definition	Revenue from healthy aging and longevity ingredients sold within the defined ingredient, application and benefit universe. Downstream finished-product revenue and adjacent or substitute product revenue are excluded.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	USA, UK, Germany, Japan, and 20+ countries included in the full report.
Key Companies Profiled	dsm-firmenich, Glanbia, Kerry, BASF, Gnosis by Lesaffre, IFF, ADM, Lallemand Health Solutions.
Forecast Period	2026 to 2036.
Approach	Primary and secondary research with market triangulation.

Healthy Aging & Longevity Ingredients Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Healthy Aging & Longevity Ingredients Market by Segments

Healthy Aging & Longevity Ingredients Market segmented by Ingredient:

• Proteins
• Collagen
• Omega-3
• Probiotics
• Botanicals
• Vitamins

Healthy Aging & Longevity Ingredients Market segmented by Application:

• Functional F&B
• Supplements
• Beverages

Healthy Aging & Longevity Ingredients Market segmented by Benefit:

• Mobility
• Cognition
• Immunity

Healthy Aging & Longevity Ingredients Market by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France
  • Nordics
  • Benelux
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan and Baltic States
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union Countries
  • Rest of Middle East and Africa

Research Sources and Bibliography

• United Nations Department of Economic and Social Affairs. (2026, February 27). UN DESA Policy Brief No. 186: Gender Matters in an Ageing World: The Case for Gender-responsive Policies.
• USA Census Bureau. (2025, June 26). Older Adults Outnumber Children in 11 States and Nearly Half of USA Counties.
• dsm-firmenich. (2026, February 20). The year in review - dsm-firmenich Integrated Annual Report 2025.
• ADM. (2025, February 25). ADM and Asahi Group Sign Exclusive Distribution Agreement for Innovative Postbiotic Designed to Support Stress, Mood and Sleep.
• Lallemand Health Solutions. (2025, March 18). Lallemand Health Solutions Launches Cerenity A Clinically Studied Probiotic Formula to Support Healthy Aging.
• dsm-firmenich. (2025, April 14). From cellular aging to gut microbiome: dsm-firmenich highlights solutions to advance nutrition at Vitafoods 2025.
• USA Food and Drug Administration. (2025, December 11). FDA Issues Letter to Industry on the DSHEA Disclaimer.
• Kerry Group. (2025, June 4). GLP-1 users report improved quality of life & better digestive comfort when consuming Kerry Group’s BC30™ Probiotic.
• National Center for Health Statistics. (2026, May). Dietary Supplement Use: United States, August 2021-August 2023.
• Department of Health and Social Care. (2026, May 19). Great Britain nutrition and health claims (NHC) register.
• German Federal Statistical Office. (2025, December 11). By 2035, one quarter of Germany's population will be aged 67 or over.
• Consumer Affairs Agency, Japan. (2025, October 1).
• dsm-firmenich. (2026, February 20). Our markets - dsm-firmenich Integrated Annual Report 2025.
• Glanbia plc. (2026, February 25). Glanbia Full Year 2025 results.
• Glanbia. (2025, October 21). Innovation uncovered: Inside Health and Nutrition.
• Kerry. (2026, July 15). From Protein to Multi-Benefit: How Dairy Innovation Is Evolving.
• BASF. (2026, February 27). Nutrition & Care.
• Gnosis by Lesaffre. (2026, June 12). MenaQ7® now recognized by JAMA Cardiology, #5 cardiovascular journal worldwide.
• IFF. (2026, May 27). From Longevity to Healthspan: Why Healthy Aging Starts in the Microbiome.
• Archer-Daniels-Midland Company. (2026, February 17). Archer-Daniels-Midland Company Form 10-K for the Year Ended December 31, 2025.
• Lallemand Health Solutions. (2026, April 3). Meet Lallemand Health Solutions at Vitafoods Barcelona 2026: Advancing Biotic Science Across Women’s Health, Healthy Aging, Cognitive Health, and Immunity.
• Gnosis by Lesaffre. (2026, February 11). MenaQ7® Olive Oil: Clinically Validated Vitamin K2 as MK-7 in Olive Oil Carrier.
• Lallemand Health Solutions. (2025, December 3). Cerenity™ by Lallemand Obtains New Canadian Health Claims.
• BASF. (2025, September 30). Joint News Release - BASF and Louis Dreyfus Company Complete Sale and Purchase Transaction for BASF’s Food and Health Performance Ingredients Business.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the healthy aging & longevity ingredients market in 2026 and 2036?
• Which demographic conditions expand the consumer base for function-focused healthy-aging nutrition across major markets?
• Why do proteins lead ingredient demand across healthy-aging formulations and repeat-use formats during 2026?
• Why does functional F&B lead application demand as brands target repeated nutrition occasions across established channels?
• What makes mobility the leading benefit category and which formulation routes support its current position?
• How do growth rates and commercialization conditions differ across USA, UK, Germany and Japan?
• Which evidence and formulation constraints delay commercialization across food and supplement product development programs?
• How do profiled companies differ in ingredient breadth and application support for healthy-aging products?